Literature DB >> 8287430

Myocardial oedema: a preventable cause of reperfusion injury?

D Garcia-Dorado1, J Oliveras.   

Abstract

Myocardial ischaemia increases cellular and extracellular osmolarity, alters membrane permeability to ions and causes moderate cell swelling and interstitial oedema. Ischaemia also reduces the mechanical resistance of the sarcolemma of myocytes, probably as a result of proteolytic digestion of the connections between cell membrane and the cellular scaffold. During reperfusion, the abrupt normalisation of extracellular osmotic pressure results in marked osmotic cell swelling. In the clinical situation, the ability of mechanical stress imposed by cell swelling to disrupt the weakened sarcolemma of viable myocytes during reperfusion has not been definitively established. Observations demonstrating the important role of mechanical stress caused by contraction and cell to cell interaction in myocyte necrosis support the hypothesis that osmotic cell swelling may actually produce lethal reperfusion injury. This hypothesis has been investigated by analysing the effect of hyperosmotic reperfusion with mannitol on final infarct size after coronary occlusion. Studies using highly hyperosmotic reperfusion after relatively short periods of ischaemia have yielded positive results, while studies using intravenous mannitol at the time of reperfusion, and more closely resembling clinical situations, have failed to detect any beneficial effect. Myocardial oedema could also contribute to postischaemic functional derangements, such as reperfusion arrhythmias and stunning, and could modify the passive mechanical properties of the infarcts and alter ventricular remodelling. Interventions aimed to limit myocardial oedema will probably not play a role as a co-adjuvant therapy in patients with acute myocardial infarction receiving thrombolytic treatment. However, they should probably form part of controlled reperfusion strategies to be evaluated in patients with acute myocardial infarction in whom reperfusion is accomplished by percutaneous transcoronary angioplasty or surgery.

Entities:  

Mesh:

Year:  1993        PMID: 8287430     DOI: 10.1093/cvr/27.9.1555

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  32 in total

1.  Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging.

Authors:  J C Nilsson; G Nielsen; B A Groenning; T Fritz-Hansen; L Sondergaard; G B Jensen; H B Larsson
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

2.  Reperfusion injury components and manifestations determined by cardiovascular MR and MDCT imaging.

Authors:  Maythem Saeed; Steve Hetts; Mark Wilson
Journal:  World J Radiol       Date:  2010-01-28

3.  Effect of hypernatremia on injury caused by energy deficiency: role of T-type Ca2+ channel.

Authors:  Viktor Pastukh; Hairu Chen; Songwei Wu; Chian Ju Jong; Mikhail Alexeyev; Stephen W Schaffer
Journal:  Am J Physiol Cell Physiol       Date:  2010-05-26       Impact factor: 4.249

4.  Contribution of the PI 3-kinase/Akt survival pathway toward osmotic preconditioning.

Authors:  Viktor Pastukh; Craig Ricci; Viktoriya Solodushko; Mahmood Mozaffari; Stephen W Schaffer
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

5.  Relationship between surface area of nonperfused myocardium and extravascular extraction of contrast agent following coronary microembolization.

Authors:  Nasser M Malyar; Lilach O Lerman; Mario Gössl; Patricia E Beighley; Erik L Ritman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-04       Impact factor: 3.619

Review 6.  Pathophysiology and pathogenesis of post-resuscitation myocardial stunning.

Authors:  Athanasios Chalkias; Theodoros Xanthos
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 7.  Non-ST-segment elevation acute coronary syndromes: targeted imaging to refine upstream risk stratification.

Authors:  Henry Chang; James K Min; Sunil V Rao; Manesh R Patel; Orlando P Simonetti; Giuseppe Ambrosio; Subha V Raman
Journal:  Circ Cardiovasc Imaging       Date:  2012-07       Impact factor: 7.792

8.  T2-weighted imaging to assess post-infarct myocardium at risk.

Authors:  Matthias G Friedrich; Han W Kim; Raymond J Kim
Journal:  JACC Cardiovasc Imaging       Date:  2011-09

9.  DCPIB is a novel selective blocker of I(Cl,swell) and prevents swelling-induced shortening of guinea-pig atrial action potential duration.

Authors:  N Decher; H J Lang; B Nilius; A Brüggemann; A E Busch; K Steinmeyer
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

Review 10.  T2-weighted cardiovascular magnetic resonance in acute cardiac disease.

Authors:  Ingo Eitel; Matthias G Friedrich
Journal:  J Cardiovasc Magn Reson       Date:  2011-02-18       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.